A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the new publication[2] of positive in vivo data, in the journal Diabetes, Metabolic Syndrome ...

In a breakthrough with promising real-world applications, a team of Rutgers biophysicists, bioengineers, and plant biologists has captured the first live images. In a groundbreaking study, researchers ...

A team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific ...

Researchers suggest the bacteria could be designed to detect pollution or nutrients, acting as sensors to help farmers ...

Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

The announcement adds to a string of setbacks in Pfizer’s bid to win a slice of the booming market that Wall Street projects ...

Identifying a key protein’s role could improve the common mental health medications and point to new treatments for inflammation-related diseases, VCU medicinal chemist Youzhong Guo says.

Cancer drugs that inhibit CDK7 rapidly shut down pathways responsible for cell proliferation within minutes. For organs to ...

Researchers have long wondered why some people with high-risk Parkinson’s gene variants develop the disease while others ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Senolytics are considered an anti-aging medication, and they’re currently used to treat a range of health conditions. And new ...